Outcomes and management of patients with mantle cell lymphoma after progression on brexucabtagene autoleucel therapy

被引:33
作者
Jain, Preetesh [1 ]
Nastoupil, Loretta [1 ]
Westin, Jason [1 ]
Lee, Hun Ju [1 ]
Navsaria, Lucy [1 ]
Steiner, Raphael E. [1 ]
Ahmed, Sairah [1 ]
Moghrabi, Omar [1 ]
Oriabure, Onyeka [1 ]
Chen, Wendy [1 ]
Badillo, Maria [1 ]
Flowers, Christopher R. [1 ]
Wang, Michael L. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Lymphoma & Myeloma, Houston, TX 77030 USA
关键词
Mantle cell lymphoma (MCL); ibrutinib; brexucabtagene autoleucel; BTK inhibitor; venetoclax; chimeric antigen receptor therapy; non-Hodgkin lymphoma;
D O I
10.1111/bjh.17197
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:E38 / E42
页数:5
相关论文
共 9 条
[1]   TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy [J].
Eskelund, Christian W. ;
Dahl, Christina ;
Hansen, Jakob W. ;
Westman, Maj ;
Kolstad, Arne ;
Pedersen, Lone B. ;
Montano-Almendras, Carmen P. ;
Husby, Simon ;
Freiburghaus, Catja ;
Ek, Sara ;
Pedersen, Anja ;
Niemann, Carsten ;
Raty, Riikka ;
Brown, Peter ;
Geisler, Christian H. ;
Andersen, Mette K. ;
Guldberg, Per ;
Jerkeman, Mats ;
Gronbaek, Kirsten .
BLOOD, 2017, 130 (17) :1903-1910
[2]   Complex Karyotype in Patients With Mantle Cell Lymphoma Predicts Inferior Survival and Poor Response to Intensive Induction Therapy [J].
Greenwell, I. Brian ;
Staton, Ashley D. ;
Lee, Michael J. ;
Switchenko, Jeffrey M. ;
Saxe, Debra F. ;
Maly, Joseph J. ;
Blum, Kristie A. ;
Grover, Natalie S. ;
Mathews, Stephanie P. ;
Gordon, Max J. ;
Danilov, Alexey V. ;
Epperla, Narendranath ;
Fenske, Timothy S. ;
Hamadani, Mehdi ;
Park, Steven I. ;
Flowers, Christopher R. ;
Cohen, Jonathon B. .
CANCER, 2018, 124 (11) :2306-2315
[3]   High-Risk Mantle Cell Lymphoma: Definition, Current Challenges, and Management [J].
Jain, Preetesh ;
Dreyling, Martin ;
Seymour, John F. ;
Wang, Michael .
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (36) :4302-4317
[4]   Efficacy of venetoclax in high risk relapsed mantle cell lymphoma (MCL) - outcomes and mutation profile from venetoclax resistant MCL patients [J].
Jain, Preetesh ;
Zhao, Shuangtao ;
Kanagal-Shamanna, Rashmi ;
Navsaria, Lucy ;
Ok, Chi Young ;
Zhang, Shaojun ;
Nomie, Krystle ;
Han, Guangchun ;
Hao, Dapeng ;
Hill, Holly A. ;
Jiang, Changying ;
Yao, Yixin ;
Nastoupil, Loretta ;
Westin, Jason ;
Fayad, Luis ;
Nair, Ranjit ;
Steiner, Raphel ;
Ahmed, Sairah ;
Samaniego, Felipe ;
Iyer, Swaminathan P. ;
Oriabure, Onyeka ;
Chen, Wendy ;
Song, Xingzhi ;
Zhang, Jianhua ;
Badillo, Maria ;
Moghrabi, Omar ;
Tang, Guilin ;
Yin, C. Cameron ;
Patel, Keyur ;
Medeiros, Leonard Jeffrey ;
Li, Shaoying ;
Vega, Francisco ;
Thirumurthi, Selvi ;
Xu, Guofan ;
Neelapu, Sattva ;
Flowers, Christopher R. ;
Romaguera, Jorge ;
Fowler, Nathan ;
Wang, Linghua ;
Wang, Michael L. .
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (06) :623-629
[5]   Genomic profiles and clinical outcomes of de novo blastoid/pleomorphic MCL are distinct from those of transformed MCL [J].
Jain, Preetesh ;
Zhang, Shaojun ;
Kanagal-Shamanna, Rashmi ;
Ok, Chi Young ;
Nomie, Krystle ;
Gonzalez, Graciela Nogueras ;
Gonzalez-Pagan, Omarya ;
Hill, Holly A. ;
Lee, Hun Ju ;
Fayad, Luis ;
Westin, Jason ;
Nastoupil, Loretta ;
Hagemeister, Frederick ;
Chen, Wendy ;
Oriabure, Onyeka ;
Badillo, Maria ;
Jiang, Changying ;
Yao Yixin ;
Li, Shaoying ;
Tang, Guilin ;
Yin, C. Cameron ;
Patel, Keyur P. ;
Medeiros, Leonard Jeffrey ;
Nair, Ranjit ;
Ahmed, Sairah ;
Iyer, Swaminathan P. ;
Thirumurthi, Selvi ;
Champlin, Richard ;
Xu, Guofan ;
Pan Tinsu ;
Santos, David ;
Wang, Ruiping ;
Han, Guangchun ;
Zhang, Jianhua ;
Song, Xingzhi ;
Neelapu, Sattva ;
Romaguera, Jorge ;
Futreal, Andy ;
Flowers, Christopher ;
Fowler, Nathan ;
Wang, Linghua ;
Wang, Michael L. .
BLOOD ADVANCES, 2020, 4 (06) :1038-1050
[6]   Long-term outcomes and mutation profiling of patients with mantle cell lymphoma (MCL) who discontinued ibrutinib [J].
Jain, Preetesh ;
Kanagal-Shamanna, Rashmi ;
Zhang, Shaojun ;
Ahmed, Makhdum ;
Ghorab, Ahmad ;
Zhang, Liang ;
Ok, Chi Young ;
Li, Shaoying ;
Hagemeister, Frederick ;
Zeng, Dongfeng ;
Gong, Tiejun ;
Chen, Wendy ;
Badillo, Maria ;
Nomie, Krystle ;
Fayad, Luis ;
Medeiros, Leonard J. ;
Neelapu, Sattva ;
Fowler, Nathan ;
Romaguera, Jorge ;
Champlin, Richard ;
Wang, Linghua ;
Wang, Michael L. .
BRITISH JOURNAL OF HAEMATOLOGY, 2018, 183 (04) :578-587
[7]   CSF1R and BTK inhibitions as novel strategies to disrupt the dialog between mantle cell lymphoma and macrophages [J].
Papin, Antonin ;
Tessoulin, Benoit ;
Bellanger, Celine ;
Moreau, Anne ;
Le Bris, Yannick ;
Maisonneuve, Herve ;
Moreau, Philippe ;
Touzeau, Cyrille ;
Amiot, Martine ;
Pellat-Deceunynck, Catherine ;
Le Gouill, Steven ;
Chiron, David .
LEUKEMIA, 2019, 33 (10) :2442-2453
[8]   KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma [J].
Wang, Michael ;
Munoz, Javier ;
Goy, Andre ;
Locke, Frederick L. ;
Jacobson, Caron A. ;
Hill, Brian T. ;
Timmerman, John M. ;
Holmes, Houston ;
Jaglowski, Samantha ;
Flinn, Ian W. ;
McSweeney, Peter A. ;
Miklos, David B. ;
Pagel, John M. ;
Kersten, Marie-Jose ;
Milpied, Noel ;
Fung, Henry ;
Topp, Max S. ;
Houot, Roch ;
Beitinjaneh, Amer ;
Peng, Weimin ;
Zheng, Lianqing ;
Rossi, John M. ;
Jain, Rajul K. ;
Rao, Arati V. ;
Reagan, Patrick M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (14) :1331-1342
[9]   Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma [J].
Zhang, Liang ;
Yao, Yixin ;
Zhang, Shaojun ;
Liu, Yang ;
Guo, Hui ;
Ahmed, Makhdum ;
Bell, Taylor ;
Zhang, Hui ;
Han, Guangchun ;
Lorence, Elizabeth ;
Badillo, Maria ;
Zhou, Shouhao ;
Sun, Yuting ;
Di Francesco, M. Emilia ;
Feng, Ningping ;
Haun, Randy ;
Lan, Renny ;
Mackintosh, Samuel G. ;
Mao, Xizeng ;
Song, Xingzhi ;
Zhang, Jianhua ;
Pham, Lan, V ;
Lorenzi, Philip L. ;
Marszalek, Joseph ;
Heffernan, Tim ;
Draetta, Giulio ;
Jones, Philip ;
Futreal, Andrew ;
Nomie, Krystle ;
Wang, Linghua ;
Wang, Michael .
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (491)